Charge: Free to attend as a Drug Developer: GBP 0.0
Uniting translational, clinical, regulatory and commercial functions, Clinical Biomarkers and World CDx Europe is your end-to-end meeting for translating exploratory signatures into clinically predictive biomarkers and overcoming key bottlenecks to driving adoption and access to game-changing diagnostic-enabled precision medicines.
Built for biopharma, clinical and diagnostic teams, this meeting provides the opportunity to tackle your biggest roadblocks and uncover new opportunities in biomarker research and drug development.
You can hear from the likes of Genomics England and LEO Pharma for 2 days of in-depth case studies, interactive panel discussions, dedicated Q+A time and highly appraised networking opportunities to meet and learn from the best in the business.
If you are dedicated to streamlining the demonstration of therapeutic efficacy, maximizing clinical success or improving the market penetration of precision medicines, this is your place to be! Join the community that's been with us now for a decade. Attendance is free for drug developers.
On Sunday January 10, 2021 at 8:00 am (ends Wednesday March 31, 2021 at 5:00 pm)
Venue details: London, Greater London, England, SW1, United Kingdom
Category: Conferences | Science, Health and Medicine | Diagnostics
Speakers: Joanne Hackett, Chief Commercial Officer, Genomics England, Clare Balendran, Vice President, Translational Medicine, Novo Nordisk, Caoimhe Vallely-Gilroy, Healthcare Data Strategy, CEO Office Healthcare, Merck KGaA, Rowena Sharpe, Director, Precision Medicine Trials, University of Birmingham, Ellie Corigliano, Global Director Medical Affairs, Oncology, Thoracic and Pan Tumor Biomarkers and Diagnostics, Oncology Global Medical Affairs, Merck and Co., Berit Mikkelsen, Global Market Access Lead, Precision Medicine, LEO Pharma